Module
Hepatitis JournalOptions – November/December 2005
Source: Journal Options
Hepatitis JournalOptions – November/December 2005
CME Program Director: Robert G. Gish, MD, David L. Thomas, MD, MPH
  
- Nezam H. Afdhal, MD, FRCPI
- Rena K. Fox, MD
- Neil Kaplowitz, MD
|
  
- Paul J. Pockros, MD
- Stuart Ray, MD
- Kathleen B. Schwarz, MD
|
|
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe new advances in hepatitis C, including treatment options for children, use of consensus interferon in nonresponders, and a cellular model for studying HCV
- Discuss circumstances leading to 2 outbreaks of hepatitis B, including the role of current vaccination practices
- Recount current statistics of acetaminophen-induced acute liver failure in the United States
- Describe the relationship between coffee and tea consumption and chronic liver disease incidence in the United States
Click "Begin Collection" to view the entire Collection with the test for CME credit. You may also download and print the entire Collection from this module.
|
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by University of Alabama School of Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|
|